Financial

CONMED (CNMD) is Upgraded by Ladenburg Thalmann to Buy

CONMED (CNMD) is Upgraded by Ladenburg Thalmann to Buy , according to the research report released to the investors. Earlier the firm had a rating of Neutral on the company shares. The shares recommendation by the Brokerage Firm was released on Oct-12-2015.

CONMED Corporation (NASDAQ:CNMD) rose 0.23% or 0.11 points on Friday and made its way into the gainers of the day. After trading began at $47.63 the stock was seen hitting $48.02 as a peak level and $47.13 as the lowest level. The stock ended up at $47.52. The daily volume was measured at 197,435 shares. The 52-week high of the share price is $60.662 and the 52-week low is $38.62. The company has a market cap of $1,316 million.

CONMED Corporation (NASDAQ:CNMD) has lost 2.42% during the past week and dropped 7.71% in the last 4 weeks. The shares are however, negative as compared to the S&P 500 for the past week with a loss of 5.5%. CONMED Corporation (NASDAQ:CNMD) has underperformed the index by 10.18% in the last 4 weeks. Investors should watch out for further signals and trade with caution.

READ MORE HERE

Print Friendly, PDF & Email
Tags

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button
Close